Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
We use essential cookies by default: sign-in, your choice in this banner (supstack-consent) and your language (NEXT_LOCALE). Vercel Web Analytics (cookieless page counts) and Sentry error reports (without replay) run either way. Only if you choose "Accept all" do we also create a browser ID in local storage (it ties your visits together in our site records), record error-replay diagnostics (Sentry: masked DOM snapshots, only when an error fires) and turn on load-time metrics (Vercel Speed Insights) so we can fix slow pages faster. Learn more about cookies
Zinc helped in 12 of 14 studies that measured an effect.
Most evidence is from high-quality meta-analyses and randomised trials published 1976–2026 with a typical study size of 739 participants.
Based on 637 studies · 103 meta-analyses · 475 RCTs · 486,979 total participants · 1 retracted study left out
Study base
637 studies indexed
What the studies found
12helped2unclear· 623 more without graded effect data
By outcome
Immune supportMay shorten colds. Little or no effect on preventing them (Cochrane 38719213) · 2-4 weeksHelped411 studies
Helped411 studies
Anemia & hematologyHelped104 studies
Helped104 studies
Women's healthZinc eased period pain in a dysmenorrhoea meta-analysis. No cited study measured estrogen metabolism · 4-8 weeks · May help reduce menstrual discomfort and PMS symptoms · 1-3 cycles · A Cochrane review of 25 trials found not enough evidence that zinc supplements in pregnancy improve maternal or newborn outcomes, birthweight included · OngoingToo few graded studies88 studies
Too few graded studies88 studies
Therapeutic & clinicalToo few graded studies60 studies
Too few graded studies60 studies
Glucose & metabolicToo few graded studies30 studies
Too few graded studies30 studies
InflammationToo few graded studies21 studies
Too few graded studies21 studies
Cognitive functionToo few graded studies13 studies
Too few graded studies13 studies
Depression & moodZinc deficiency associated with depression; repletion improves mood · 4-8 weeksToo few graded studies12 studies
Too few graded studies12 studies
Safety profileToo few graded studies12 studies
Too few graded studies12 studies
Skin healthMay reduce inflammatory acne, mainly where zinc intake is low (oral) · 8-12 weeks · Supports wound healing, keratinocyte function, and reduces acne · 4-8 weeksToo few graded studies9 studies
Too few graded studies9 studies
Taste & smellToo few graded studies9 studies
Too few graded studies9 studies
Cholesterol & lipidsToo few graded studies9 studies
Too few graded studies9 studies
Heart & blood pressureToo few graded studies7 studies
Too few graded studies7 studies
Men's vitalityIn an open-label study of marginally zinc-deficient older men, testosterone rose. No evidence without deficiency · 4-8 weeks · Cofactor for prostate function · Cofactor for testosterone productionToo few graded studies4 studies
Too few graded studies4 studies
Fertility & reproductiveNo trial has tested zinc for women's fertility, and in the largest trial, 2,370 couples, zinc plus folic acid given to the male partner did not raise live births (34% vs 35%). · 4-12 weeksToo few graded studies4 studies
Too few graded studies4 studies
Anxiety & stressToo few graded studies4 studies
Too few graded studies4 studies
Bone healthCofactor for bone formation enzymes and osteoblast activity · 8-12 weeksToo few graded studies3 studies
Too few graded studies3 studies
Sleep & insomniaImproved sleep quality · 2-4 weeks · Zinc status linked to sleep quality and durationToo few graded studies3 studies
Too few graded studies3 studies
Focus & attentionToo few graded studies2 studies
Too few graded studies2 studies
Vision & eye healthToo few graded studies2 studies
Too few graded studies2 studies
Energy & fatigueToo few graded studies1 study
Too few graded studies1 study
By the numbers
Pulled from 55 studies with measurable effects
Likely real effects
80%
across studies
People studied
487k
typical study: 739 people
Strongest designs
578
103 pooled, 475 randomised
Showed benefit
86%
12/14 studies
How long studies ran
1–4 weeks
1
1–3 months
5
3+ months
9
Populations Studied
Pregnant women3
Adults2
Various populations2
General population2
Steady research
120 studies in the last 5 years · Latest meta-analysis: 2026
197620012026
1Lipid profile improvementMeta-AnalysisCited 15×n=1,067 · large study2023
In plain English: Significant improvement was observed in all 4 lipid profile components.
Heidari Seyedmahalleh M et al. · Advances in nutrition (Bethesda, Md.) (2023)
Noticeable benefit
← WorseNo effectBetter →
Likely real
Significant improvement was observed in all 4 lipid profile components.
Following zinc supplementation, a significant decrease was observed in TC (weighted mean difference [WMD]: -16.16; 95% confidence interval [CI]: -26.43, -5.89; P = 0.002), LDL (WMD: -6.18; 95% CI: -9.35, -3.02; P < 0.001), and TG (WMD: -13.08; 95% CI: -21.83, -4.34; P = 0.003).
After analyzing 13 studies reporting HDL, a significant increase was seen (WMD: 3.76; 95% CI: 1.30, 6.22; P = 0.003).
2Preterm birth risk reductionMeta-AnalysisCited 51×n=9,851 · very large study2021
In plain English: There is not enough evidence that zinc supplementation during pregnancy results in improvements in maternal or neonatal outcomes.
Carducci B et al. · The Cochrane database of systematic reviews (2021)
No clear effect
← WorseNo effectBetter →
The evidence suggests that zinc supplementation may result in little or no difference in reducing preterm births (risk ratio (RR) 0.87, 95% confidence interval (CI) 0.74 to 1.03; 21 studies, 9851 participants; low-certainty evidence).
Further, zinc supplementation may make little or no difference in reducing the risk of stillbirth (RR 1.22, 95% CI 0.80 to 1.88; 7 studies, 3295 participants; low-certainty evidence), or perinatal deaths (RR 1.10, 95% CI 0.81 to 1.51; 2 studies, 2489 participants; low-certainty evidence).
There is not enough evidence that zinc supplementation during pregnancy results in improvements in maternal or neonatal outcomes.
3Pain severity reduction in primary dysmenorrheaMeta-AnalysisCited 3×n=739 · large study2024
In plain English: Zinc supplementation is an effective and well-tolerated option for reducing pain severity in women with primary dysmenorrhea.
Hsu TJ et al. · Nutrients (2024)
Huge benefit
← WorseNo effectBetter →
Likely real
Zinc supplementation significantly reduced pain severity compared to placebo (Hedges's g = -1.541; 95% CI: -2.268 to -0.814; p < 0.001), representing a clinically meaningful reduction in pain.
Meta-regression indicated that longer treatment durations (≥8 weeks) were associated with greater pain reduction (p = 0.003).
While higher zinc doses provided additional pain relief, the incremental benefit per additional milligram was modest (regression coefficient = -0.02 per mg; p = 0.005).
4Prevention of respiratory tract infectionsMeta-AnalysisCited 40×n=5,446 · very large study2021
In plain English: In adult populations unlikely to be zinc deficient, there was some evidence suggesting zinc might prevent RTIs symptoms and shorten duration.
Hunter J et al. · BMJ open (2021)
Noticeable benefit
← WorseNo effectBetter →
Compared with placebo, oral or intranasal zinc prevented 5 RTIs per 100 person-months (95% CI 1 to 8, numbers needed to treat (NNT)=20, moderate-certainty/quality).
Sublingual zinc did not prevent clinical colds following human rhinovirus inoculations (relative risk, RR 0.96, 95% CI 0.77 to 1.21, moderate-certainty/quality).
On average, symptoms resolved 2 days earlier with sublingual or intranasal zinc compared with placebo (95% CI 0.61 to 3.50, very low-certainty/quality) and 19 more adults per 100 were likely to remain symptomatic on day 7 without zinc (95% CI 2 to 38, NNT=5, low-certainty/quality).
5Prevalence of zinc deficiency in IBDMeta-AnalysisCited 40×n=806 · large study2022
In plain English: Clinicians in the field are advised to list zinc among trace elements to be monitored in serum.
Zupo R et al. · Nutrients (2022)
Pooled analyses by the IBD subgroup showed a total population of 1677 with CD, for an overall mean zinc deficiency prevalence of 54% and 95% confidence intervals (CI) ranging from 0.51 to 0.56, versus 41% (95%CI 0.38-0.45) in the UC population (n = 806).
The overall prevalence at meta-analysis was estimated at 50% (95%CI 0.48-0.52), but with high heterogeneity, I2 = 96%.
The risk of bias across selected studies was moderate to low.
6Meta-AnalysisCited 169×n=451,723 · very large study2020
In plain English: In addition, they further contribute to the ongoing discourse of choosing antenatal MMN over IFA as the standard of care in LMICs.
Oh C et al. · Nutrients (2020)
IFA supplementation showed notable improvement in maternal anemia and the reduction in low birthweight, whereas LNS supplementation had no apparent effect on outcomes; further research that compares LNS and MMN supplementation could help understand differences with these commodities.
For single micronutrient supplementation, improvements were noted in only a few outcomes, mainly pre-eclampsia/eclampsia (calcium), maternal anemia (iron), preterm births (vitamin D), and maternal serum zinc concentration (zinc).
These findings highlight that micronutrient-specific supplementation should be tailored to specific groups or needs for maximum benefit.